Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Prostatic Neoplasms 1Myeloproliferative Disorders 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Cardiovascular Diseases 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 13Peripheral Blood Stem Cell Transplantation 12Cyclophosphamide 12Cyclosporine 11Busulfan 9Mycophenolic Acid 8Filgrastim 8Antilymphocyte Serum 8Whole-Body Irradiation 7Radiotherapy 5Methotrexate 5Methylprednisolone 4Melphalan 4Cord Blood Stem Cell Transplantation 4Tacrolimus 3Cytarabine 3Psychiatric Rehabilitation 2Granulocyte Colony-Stimulating Factor 2Flow Cytometry 2Etoposide 2Early Intervention, Educational 2Dexamethasone 2Calcium Dobesilate 2Aprepitant 2thymoglobulin 1sargramostim 1plerixafor 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Congenital Abnormalities × Pravastatin × Clear all
NCT01831232 2017-11-17

Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Fred Hutchinson Cancer Center

Phase NA Completed
24 enrolled 11 charts
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡